Genomic biomarker development to impact clinical management of patients at risk for lung cancer
Lung cancer is the leading cause of cancer mortality in the US and the world, largely due to the challenges with early detection and precision management of aggressive cancer. We previously derived and validated bronchial and nasal epithelial gene expression biomarkers to detect lung cancer among in...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/41252 |